tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Denys-Drash Syndrome D030321 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Leukoplakia D007971 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Mediastinitis D008480 2 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ileus D045823 3 associated lipids
Rectal Diseases D012002 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Gołębiewska J et al. Tako-tsubo cardiomyopathy on the first day after renal transplantation - case report and literature review. 2014 Transplant. Proc. pmid:25380951
Ünlüsoy Aksu A et al. Immune thrombocytopenic purpura in a liver transplant patient. 2014 Exp Clin Transplant pmid:24635822
Kamińska D et al. Significant infections after hand transplantation in a Polish population. 2014 Transplant. Proc. pmid:25380943
Bakkour W et al. Successful use of dapsone for the management of circinate balanitis. 2014 Clin. Exp. Dermatol. pmid:24635073
Venkat VL et al. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients. 2014 Liver Transpl. pmid:24634351
Kapoor K et al. Lip hypertrophy due to cyclosporine therapy. 2014 Clin. Exp. Nephrol. pmid:23615783
Kiiski V et al. Long-term safety of topical pimecrolimus and topical tacrolimus in atopic blepharoconjunctivitis. 2014 JAMA Dermatol pmid:24500107
Naganuma M et al. [Clinical relevance of tacrolimus trough levels in outpatients with active ulcerative colitis]. 2014 Nihon Shokakibyo Gakkai Zasshi pmid:24500317
Sahin S et al. The protective effects of tacrolimus on rat uteri exposed to ischemia-reperfusion injury: a biochemical and histopathologic evaluation. 2014 Fertil. Steril. pmid:24502894
Ciancio G et al. Randomized trial of three induction antibodies in kidney transplantation: long-term results. 2014 Transplantation pmid:24477186
Okada K et al. [Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]. 2014 Rinsho Ketsueki pmid:24492043
Méndez A et al. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. 2014 Transplantation pmid:24492423
Hartmann A et al. Treatment of generalised vitiligo with tacrolimus 0.1% ointment vs. UVB intense pulsed light phototherapy: a pilot study. 2014 Acta Derm. Venereol. pmid:24473666
Xu H et al. The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. 2014 Am. J. Transplant. pmid:24472192
Tsuchimoto A et al. Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients. 2014 PLoS ONE pmid:25329716
Lankarani KB et al. Response to: Comment on: New-onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose. 2014 Exp Clin Transplant pmid:24471728
Qi H et al. The antiaging activity and cerebral protection of rapamycin at micro-doses. 2014 CNS Neurosci Ther pmid:25327787
Kabir A Comment on: New-onset diabetes and impaired fasting glucose after a liver transplant: risk analysis and the effect of tacrolimus dosage. 2014 Exp Clin Transplant pmid:24471727
Kuypers DR et al. Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients. 2014 Pharmacogenet. Genomics pmid:25322286
Kim H et al. Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. 2014 Clin Mol Hepatol pmid:25320733
Curtin BF et al. Unusually late-onset mycophenolate mofetil-related colitis. 2014 Am J Health Syst Pharm pmid:25320135
Zheng X et al. Patient with neuromyelitis optica spectrum disorder combined with Sjögren's syndrome relapse free following tacrolimus treatment. 2014 Intern. Med. pmid:25318807
Ramachandran R et al. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. 2014 Nephrol. Dial. Transplant. pmid:24771498
Daher Abdi Z et al. Exposure to mycophenolic acid better predicts immunosuppressive efficacy than exposure to calcineurin inhibitors in renal transplant patients. 2014 Clin. Pharmacol. Ther. pmid:24968086
Capone F et al. Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines. 2014 ScientificWorldJournal pmid:24701168
Kato H et al. Significant improvement of Takayasu arteritis after cord blood transplantation in a patient with myelodysplastic syndrome. 2014 Bone Marrow Transplant. pmid:24317130
Tischer S and Fontana RJ Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. 2014 J. Hepatol. pmid:24280292
Iwanami M et al. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis]. 2014 Rinsho Shinkeigaku pmid:24429649
Xu W et al. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time. 2014 Int J Pharm pmid:24172796
Sivakumar V et al. Role of fludrocortisone in the management of tacrolimus-induced hyperkalemia in a renal transplant recipient. 2014 Saudi J Kidney Dis Transpl pmid:24434399
Yargui L et al. Metabolic status of 1088 patients after renal transplantation: assessment of twelve years monitoring in Algiers Mustapha Hospital. 2014 Saudi J Kidney Dis Transpl pmid:24434409
Urbanowicz T et al. Induction therapy, tacrolimus plasma concentration, and duration if intensive care unit stay are risk factors for peripheral leucopenia following heart transplantation. 2014 Ann. Transplant. pmid:25274118
Gounden V and Soldin SJ Tacrolimus measurement: building a better immunoassay. 2014 Clin. Chem. pmid:24415738
Takeuchi T et al. Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis. 2014 Mod Rheumatol pmid:24261753
Posadas Salas MA and Srinivas TR Update on the clinical utility of once-daily tacrolimus in the management of transplantation. 2014 Drug Des Devel Ther pmid:25210441
Arduino PG et al. Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized double-blind controlled study. 2014 J Eur Acad Dermatol Venereol pmid:23451852
Wasilewski G et al. Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? 2014 Transplant. Proc. pmid:25380929
Nasu R et al. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. 2014 Ann. Hematol. pmid:24590535
Kujawski S et al. Calcineurin regulates coordinated outgrowth of zebrafish regenerating fins. 2014 Dev. Cell pmid:24561038
Eguchi R et al. Recombinant human soluble thrombomodulin attenuates FK506-induced endothelial dysfunction through prevention of Akt inactivation. 2014 Exp. Cell Res. pmid:24582967
Baldo A et al. Vitiligo, NB-UVB and tacrolimus: our experience in Naples. 2014 G Ital Dermatol Venereol pmid:24566573
Liu FL et al. FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines. 2014 J. Biosci. pmid:24499793
Giordanetto F and Kihlberg J Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties? 2014 J. Med. Chem. pmid:24044773
Sun Z et al. Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics. 2014 Int Urol Nephrol pmid:25145781
Murota H et al. Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model. 2014 Acta Derm. Venereol. pmid:23817562
Dannhorn E et al. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up. 2014 Clin Transplant pmid:25142496
Noceti OM et al. Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes. 2014 Clin. Chem. pmid:25142246
Feliu J et al. Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. 2014 Br. J. Haematol. pmid:24962133
Calo S et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. 2014 Nature pmid:25079329
Chen SR et al. Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords. 2014 J. Physiol. (Lond.) pmid:24081160
Ko SF et al. Therapeutic potential of tacrolimus on acute myocardial infarction in minipigs: analysis with serial cardiac magnetic resonance and changes at histological and protein levels. 2014 Biomed Res Int pmid:25114905
Grossman J et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. 2014 Biol. Blood Marrow Transplant. pmid:25111582
Grafals M et al. Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study. 2014 PLoS ONE pmid:25111080
Guillén-Gómez E et al. Monocyte implication in renal allograft dysfunction. 2014 Clin. Exp. Immunol. pmid:24134783
Freire-Cobo C et al. The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus. 2014 J Neuroimmune Pharmacol pmid:25104570
Aelvoet SA et al. Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters. 2014 J. Neurosci. pmid:25471588
Oh CK et al. Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. 2014 Yonsei Med. J. pmid:25048494
Matin M et al. The effectiveness of excimer laser on vitiligo treatment in comparison with a combination therapy of Excimer laser and tacrolimus in an Iranian population. 2014 J Cosmet Laser Ther pmid:25046236
de la Fuente V et al. Calcineurin phosphatase as a negative regulator of fear memory in hippocampus: control on nuclear factor-κB signaling in consolidation and reconsolidation. 2014 Hippocampus pmid:25043904
Klintmalm GB et al. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. 2014 Am. J. Transplant. pmid:25041339
Ikeuchi H et al. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis. 2014 Mod Rheumatol pmid:24252014
Miyauchi T et al. Evidence for the therapeutic efficacy of either mild hypothermia or oxygen radical scavengers after repetitive mild traumatic brain injury. 2014 J. Neurotrauma pmid:24341607
Gujadhur A et al. CMV sinusitis in a HIV-negative renal transplant recipient. 2014 Transplantation pmid:24827770
Garriga-Companys S and Labrador-Horrillo M [Chronic spontaneous urticaria]. 2014 Med Clin (Barc) pmid:24120109
Inaba A et al. Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid. 2014 Rinsho Ketsueki pmid:24850458
Kurzawski M et al. Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients. 2014 Pharmacogenet. Genomics pmid:24921414
Qi H et al. Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis. 2014 J. Ind. Microbiol. Biotechnol. pmid:24965502
Zhao J et al. FK506-loaded chitosan conduit promotes the regeneration of injured sciatic nerves in the rat through the upregulation of brain-derived neurotrophic factor and TrkB. 2014 J. Neurol. Sci. pmid:24954089
Hacker C et al. Falsely elevated cyclosporin and tacrolimus concentrations over prolonged periods of time due to reversible adsorption to central venous catheters. 2014 Clin. Chim. Acta pmid:24631133
Hallowell RW and Danoff SK Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. 2014 Curr Opin Rheumatol pmid:25203119
Saito E et al. Efficacy of salvage therapy and its effect on operative outcomes in patients with ulcerative colitis. 2014 Digestion pmid:24458114
Song L et al. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys. 2014 Transplantation pmid:24992357
Hayes D et al. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. 2014 Pediatr. Neurol. pmid:24405697
Hosohata K et al. Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients. 2014 Drug Metab. Pharmacokinet. pmid:23955548
Langone A et al. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation. 2014 Clin Transplant pmid:24893821
Nafar M et al. Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients. 2014 Iran J Kidney Dis pmid:24878947
van Gelder T Within-patient variability in immunosuppressive drug exposure as a predictor for poor outcome after transplantation. 2014 Kidney Int. pmid:24875549
Lalan S et al. Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population. 2014 Pediatr. Nephrol. pmid:24875272
Ricardo E et al. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. 2014 Antimicrob. Agents Chemother. pmid:24867987
Tümgör G et al. A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. 2014 Turk J Gastroenterol pmid:25599790
Korbel L et al. Clinically relevant pharmacogenomic testing in pediatric practice. 2014 Clin Pediatr (Phila) pmid:24803633
Kallash M and Aviles D Efficacy of tacrolimus in the treatment of children with focal segmental glomerulosclerosis. 2014 World J Pediatr pmid:24801235
Maeda H et al. Disappearance of GFP-positive hepatocytes transplanted into the liver of syngeneic wild-type rats pretreated with retrorsine. 2014 PLoS ONE pmid:24796859
Du W et al. Improved FK506 production by the precursors and product-tolerant mutant of Streptomyces tsukubaensis based on genome shuffling and dynamic fed-batch strategies. 2014 J. Ind. Microbiol. Biotechnol. pmid:24788378
Ishikawa Y and Bächinger HP A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. 2014 J. Biol. Chem. pmid:24821723
Agrawal YP et al. Transplant patient classification and tacrolimus assays: more evidence of the need for assay standardization. 2014 Ther Drug Monit pmid:24784024
Sageshima J et al. Everolimus with low-dose tacrolimus in simultaneous pancreas and kidney transplantation. 2014 Clin Transplant pmid:24779669
Nkongolo S et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. 2014 J. Hepatol. pmid:24295872
Pandey S et al. Metabotropic glutamate receptor 1 recycles to the cell surface in protein phosphatase 2A-dependent manner in non-neuronal and neuronal cell lines. 2014 J. Neurochem. pmid:25113668
Al-Kadhimi Z et al. High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. 2014 Biol. Blood Marrow Transplant. pmid:24709007
Madian AG et al. Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution. 2014 BMC Pharmacol Toxicol pmid:25472557
Indriolo A and Ravelli P Clinical management of inflammatory bowel disease in the organ recipient. 2014 World J. Gastroenterol. pmid:24707135
Huang W et al. Tacrolimus (FK506) suppresses TREM-1 expression at an early but not at a late stage in a murine model of fungal keratitis. 2014 PLoS ONE pmid:25464008
Nair S and Waters B Telaprevir in treatment of recurrent hepatitis C infection in liver transplant recipients. 2014 Exp Clin Transplant pmid:24702143
Manousou P et al. Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. 2014 Gut pmid:24131637
Lee SK et al. Overexpression of the putative extracytoplasmic function sigma (σ) factor FujE enhances FK506 production in Streptomyces sp. strain KCCM 11116P. 2014 Can. J. Microbiol. pmid:24869633
Navas-López VM et al. Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine. 2014 Clin J Gastroenterol pmid:26185880
van der Vusse ML et al. Helicobacter canis bacteremia in a renal transplant patient. 2014 Transpl Infect Dis pmid:24372779
Földes G et al. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. 2014 Stem Cells Dev. pmid:24192059
Lee CH et al. Raised tacrolimus level and acute renal injury associated with acute gastroenteritis in a child receiving local rectal tacrolimus. 2014 Clin J Gastroenterol pmid:26183743